Autologous non‐human primate model for safety assessment of piggyBac transposon‐mediated chimeric antigen receptor T cells on granulocyte–macrophage colony‐stimulating factor recep...

por Morokawa, Hirokazu, Yagyu, Shigeki, Hasegawa, Aiko, Tanaka, Miyuki, Saito, Shoji, Mochizuki, Hidemi, Sakamoto, Kengo, Shimoi, Akihito, Nakazawa, Yozo
Publicado 2020

A lymphodepleted non‐human primate model for the assessment of acute on‐target and off‐tumor toxicity of human chimeric antigen receptor‐T cells

por Yagyu, Shigeki, Mochizuki, Hidemi, Yamashima, Kumiko, Kubo, Hiroshi, Saito, Shoji, Tanaka, Miyuki, Sakamoto, Kengo, Shimoi, Akihito, Nakazawa, Yozo
Publicado 2021

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

por Chinsuwan, Thanyavi, Hirabayashi, Koichi, Mishima, Shuji, Hasegawa, Aiko, Tanaka, Miyuki, Mochizuki, Hidemi, Shimoi, Akihito, Murakami, Takashi, Yagyu, Shigeki, Shimizu, Kimihiro, Nakazawa, Yozo
Publicado 2023

Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers

por Chinsuwan, Thanyavi, Hirabayashi, Koichi, Mishima, Shuji, Hasegawa, Aiko, Tanaka, Miyuki, Mochizuki, Hidemi, Shimoi, Akihito, Murakami, Takashi, Yagyu, Shigeki, Shimizu, Kimihiro, Nakazawa, Yozo
Publicado 2023